Carrillo, MD, evaluates the current state of the global availability of clinical trials for patients with renal cell ...

There were a number of notable developments for patients with kidney cancer at the symposium, Dr. Emre Yekedüz explained.

examine the levels of glycoprotein non-metastatic melanoma protein ... based predicter of treatment response in clear cell renal cell carcinoma. Here, the authors use deep learning to infer ...

hereditary leiomyomatosis manifesting as a cystic renal lesion, cystic nephroma, clear cell papillary RCC, and other cystic lesions of the kidney. These cystic tumors are extremely difficult to ...

Metastatic ccRCC tumors with high PSMA gene expression have a high rate of angiogenesis, which may predict a better response to antiangiogenic therapies such as TKIs. Prostate-specific membrane ...